Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Samrat Pharmachem Ltd
Your Vote -
Buy
66.67%
Hold
16.67%
Sell
16.67%
66.67%
6 users have voted
Option Chain
Analyzes market sentiment, predicts Samrat Pharmachem Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Samrat Pharma - Announcement under Regulation 30 (LODR)-Credit Rating
-
Samrat Pharma posts Q4 net loss of Rs 0.40 cr
-
Samrat Pharma - Audited Financial Results For The Year Ended March 31, 2025
-
Samrat Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held Today
-
Samrat Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Samrat Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Samrat Pharma - Board Meeting Intimation for Notice Of Board Meeting For Approval Of Audited Financial Results For The Financ
Key fundamentals
Evaluate the intrinsic value of Samrat Pharmachem Ltd stock
Name | March-25 | March-24 | March-23 | March-22 | March-21 |
---|---|---|---|---|---|
Assets | 81.7151 | 73.4517 | 81.8026 | 54.3414 | 38.4305 |
Liabilities | 81.7151 | 73.4517 | 81.8026 | 54.3414 | 38.4305 |
Equity | 3.0897 | 3.0897 | 3.0897 | 3.0897 | 3.0897 |
Gross Profit | 10.2415 | 2.4695 | 23.9274 | 24.3433 | 8.6683 |
Net Profit | 7.1122 | 2.1626 | 16.6305 | 17.1849 | 5.3331 |
Cash From Operating Activities | -10.0914 | 9.412 | -9.4368 | 17.7819 | 4.8343 |
NPM(%) | 2.48 | 0.76 | 5.35 | 7.74 | 2.97 |
Revenue | 285.8605 | 281.5812 | 310.6459 | 221.8117 | 179.0177 |
Expenses | 275.619 | 279.1117 | 286.7185 | 197.4684 | 170.3494 |
ROE(%) | 9.9 | 3.01 | 23.16 | 23.93 | 7.42 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Samrat Pharmachem Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 859.90 | 1.12 | 28.38 | 200.41 | 301.39 | 0.58 |
Lotus Eye Hospital and Institute Ltd | 72.27 | -2.54 | 205.89 | 730.26 | 3.55 | 0.00 |
Bharat Immunological and Biologicals Corporation Ltd | 26.00 | 1.13 | 0.00 | 1516.27 | -39.50 | 0.00 |
Astec Lifesciences Ltd | 806.15 | -0.38 | 0.00 | 688.57 | -687.10 | 0.00 |
Company Info
Samrat Phannachem Limited was incorporated as Private Limited Company on 16th June 1992, under the Companies Act, 1956 in the State of Gujarat and subsequently converted into a public limited company on 24th July, 1992. Samrat Pharmachem Limited is going for an expansion of its facilities for manufacture of Bulk Drugs at Ankleshwar, Gujarat, it has taken over the unit comprising of land & building, machinery and other assets and liabilities costing Rs.30.64 lacs from M/s. Lub-chem, Bombay a partnerahip firm, promoted by the same management at book value on 1st April 1993. THE MAIN OBJECTS OF THE COMPANY The main objects of the company as set out in the Memorandum & Articles of Association are as follows: To carry on the business as manufacturers, manufacturer's representatives, dealers, traders, factors, agents, suppliers, stockists, packers, distributors, exporters, and importers of all kinds, types, nature and description of medicine, drugs, drug intermediates, pharmaceuticals, mixtures, powders, tablets, capsules, injunctions, compounds, formulations, nutrients, health products, creams, lotions, syrups, tonics, biological and biochemical products, pills, mother tinctures, triturations, glucose, nourishment foods, ointment, surgical dressings, water for injections and medical preparations, required for or used in allopathic ayurvedic, unani, homeopathic and nature cure treatments for prevention or prophylactic cure for human beings, animals, insects and birds. SUBSIDIARIES The company does not have any subsidiary at present. PRESENT BUSINESS OF THE COMPANY The Company is currently engaged in the manufacture and export of pharmaceutical bulk drugs, namely Potassium Iodide IP, Potassium Iodate IP, Iodine IP and Ferrous Fumerate IP. The Company has achieved a turnover of Rs.153.51 lacs and cash profit of Rs 8.79 lacs during the five month period ended 31st August, 1994. The Company exports its goods to Singapore, Japan, U.S.A. and other countries. For the year ended March 1994 the Company has achieved direct and indirect exports worth Rs.35.59 lacs. For period from April 1994 to August 1994, it has achieved direct exports worth Rs.12.24 lacs & it has exported goods worth Rs.25.15 lacs through Export House & Merchant Exporters. 2008 -E-mail ID for Investors Complaints:samrat@bom4.vsnl.net.in 2013 -Samrat Pharmachem Ltd has informed that Companys Corporate Office Address effective from April 01, 2013 as under :701 / 702, Business Square, M. A. Road, Andheri (West), Mumbai - 400058. Tel: (91-22) 26701050 / 1 / 2 Fax: (91-22) 26701053 Email: samrat@bom4.vsnl.net.in Web: www.samratpharmachem.com 2021 -SPL received Authorized Economic Operator (AEO) Certificate from Indian Customs. 2023 -SPL received FDA Licence. -SPL received Good Manufacturing Practices (GMP) & Good Laboratory Practices (GLP) Certificates from FDA.
Samrat Phannachem Limited was incorporated as Private Limited Company on 16th June 1992, under the Companies Act, 1956 in the State of Gujarat and subsequently converted into a public limited company on 24th July, 1992. Samrat Pharmachem Limited is going for an expansion of its facilities for manufacture of Bulk Drugs at Ankleshwar, Gujarat, it has taken over the unit comprising of land & building, machinery and other assets and liabilities costing Rs.30.64 lacs from M/s. Lub-chem, Bombay a partnerahip firm, promoted by the same management at book value on 1st April 1993. THE MAIN OBJECTS OF THE COMPANY The main objects of the company as set out in the Memorandum & Articles of Association are as follows: To carry on the business as manufacturers, manufacturer's representatives, dealers, traders, factors, agents, suppliers, stockists, packers, distributors, exporters, and importers of all kinds, types, nature and description of medicine, drugs, drug intermediates, pharmaceuticals, mixtures, powders, tablets, capsules, injunctions, compounds, formulations, nutrients, health products, creams, lotions, syrups, tonics, biological and biochemical products, pills, mother tinctures, triturations, glucose, nourishment foods, ointment, surgical dressings, water for injections and medical preparations, required for or used in allopathic ayurvedic, unani, homeopathic and nature cure treatments for prevention or prophylactic cure for human beings, animals, insects and birds. SUBSIDIARIES The company does not have any subsidiary at present. PRESENT BUSINESS OF THE COMPANY The Company is currently engaged in the manufacture and export of pharmaceutical bulk drugs, namely Potassium Iodide IP, Potassium Iodate IP, Iodine IP and Ferrous Fumerate IP. The Company has achieved a turnover of Rs.153.51 lacs and cash profit of Rs 8.79 lacs during the five month period ended 31st August, 1994. The Company exports its goods to Singapore, Japan, U.S.A. and other countries. For the year ended March 1994 the Company has achieved direct and indirect exports worth Rs.35.59 lacs. For period from April 1994 to August 1994, it has achieved direct exports worth Rs.12.24 lacs & it has exported goods worth Rs.25.15 lacs through Export House & Merchant Exporters. 2008 -E-mail ID for Investors Complaints:samrat@bom4.vsnl.net.in 2013 -Samrat Pharmachem Ltd has informed that Companys Corporate Office Address effective from April 01, 2013 as under :701 / 702, Business Square, M. A. Road, Andheri (West), Mumbai - 400058. Tel: (91-22) 26701050 / 1 / 2 Fax: (91-22) 26701053 Email: samrat@bom4.vsnl.net.in Web: www.samratpharmachem.com 2021 -SPL received Authorized Economic Operator (AEO) Certificate from Indian Customs. 2023 -SPL received FDA Licence. -SPL received Good Manufacturing Practices (GMP) & Good Laboratory Practices (GLP) Certificates from FDA.
Read More
Parent Organisation
Samrat Pharmachem Ltd.
Founded
16/06/1992
Managing Director
Mr.Lalit Mehta
NSE Symbol
FAQ
The current price of Samrat Pharmachem Ltd is
The 52-week high for Samrat Pharmachem Ltd is
The market capitalization of Samrat Pharmachem Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Samrat Pharmachem Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Samrat Pharmachem Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Samrat Pharmachem Ltd shares.
The CEO of Samrat Pharmachem Ltd is Mr.Lalit Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.